In Brief: St. Jude
This article was originally published in The Gray Sheet
Executive Summary
St. Jude: Pacesetter division launches Trilogy DR+ in Europe following CE mark approval of the dual chamber, rate responsive pacemaker. European approval is pending for the Trilogy SR+ single chamber, rate responsive device. The DR+ and SR+ Trilogy models have been in clinical trials in the U.S. since December 1994; approval is anticipated in 1996, the firm states. Trilogy DR, SR and DC models have already received EU and FDA approval ("The Gray Sheet" June 26, In Brief)...